ArticleAbdominal radiology (New York)2026
Multiparametric diffusion-weighted MRI for renal microstructural assessment in patients with primary aldosteronism at varying direct renin concentrations.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeTo utilize multiparametric diffusion-weighted imaging (DWI) to detect and quantify renal microstructural alterations in patients with primary aldosteronism (PA) at varying direct renin concentrations (DRC), and to explore the correlations between DWI-derived biomarkers and renal function biochemical indices. MATERIALS AND
methodsThis study included 50 patients and 32 healthy controls (HCs). Participants underwent 3.0 T MRI using monoexponential, intravoxel incoherent motion, and stretched-exponential DWI models. Two observers independently analyzed diffusion parameters, including apparent diffusion coefficient (ADC), fraction of fast diffusion (f), slow diffusion coefficient (Ds), fast diffusion coefficient (Df), distributed diffusion coefficient (DDC), and anomalous exponent (α). Group comparisons were conducted using t-tests, Mann-Whitney U tests, or ANOVA; receiver operating characteristic (ROC) curve analysis was used. Correlations between diffusion parameters and renal function biomarkers were analyzed using Pearson or Spearman correlation tests.
resultsCompared to HCs, PA patients with abnormal DRC exhibited significantly lower cortical and medullary ADC, f, and DDC values and higher cortical α. ROC analysis demonstrated that combining these parameters achieved an AUC of 0.884 with 90.0% sensitivity and 81.5% specificity for distinguishing DRC-abnormal patients from HCs. Medullary f was reduced in the abnormal DRC group versus normal DRC group. The ROC analysis for distinguishing these two groups yielded an AUC of 0.790, with a sensitivity of 85.30% and a specificity of 62.50%. Correlations showed an inverse relationship between medullary Ds and creatinine, a positive correlation between medullary f and uric acid, and a negative correlation of cortical DDC with creatinine and cystatin C.
conclusionMultiparametric DWI enables precise detection and quantification of renal microstructural abnormalities in PA patients. Patients with abnormal DRC exhibit more pronounced renal microstructural alterations compared to DRC-normal group. Notably, observed correlations between specific diffusion metrics and renal function biomarkers underscore their potential clinical applicability for non-invasive monitoring of PA-associated renal injury.
Indexed as
Identifiers
40824536What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.